Search results
31 maj 2012 · According to the FDA analysis of the FLEX trial, the rates of vertebral and nonvertebral osteoporotic fractures were similar whether participants continued to receive alendronate (Fosamax) for up...
Medscape - Osteoporosis-specific dosing for Fosamax, Binosto (alendronate), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and...
1 lut 2018 · Compare the data obtained with two formulations of alendronate 70 mg (tablets vs effervescent tablet for buffered solution) on the change in bone turnover markers, on gastric tolerance and on treatment adherence (including compliance and persistence).
29 wrz 2023 · Approaches to making treatment decisions and supporting patients when prescribing bisphosphonates for osteoporosis vary in practice. This study points to the need to co-ordinate osteoporosis treatment and care across different care providers.
Compare Binosto vs Fosamax head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int. 1999;9 (5):461-8. doi: 10.1007/pl00004171.
Objective: The FACT study (Fosamax Actonel Comparison Trial) was a 1-year-head-to-head trial comparing the efficacy and tolerability of once weekly (DW) alendronate 70 mg and OW risedronate 35 mg for the treatment of postmenopausal osteoporosis.
